Quantification of superparamagnetic iron oxide‐mediated signal intensity change in patients with liver cirrhosis using T2 and T2* mapping: A preliminary report
Open Access
- 24 May 2010
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 31 (6) , 1379-1386
Abstract
Purpose: To quantify the accumulation of superparamagnetic iron oxide (SPIO) in patients with and without liver cirrhosis using T2 and T2* mapping.Materials and Methods: We enrolled 10 patients without liver cirrhosis and 30 patients with liver cirrhosis (Child‐Pugh class A, n = 18; and B/C, n = 12). T2 and T2* mapping were performed before and after SPIO administration. The reductions in T2 (ΔT2) and T2* (ΔT2*) after SPIO administration were compared between the control and liver cirrhosis groups and the control, Child‐Pugh A, and Child Pugh B/C groups.Results: There were significant differences in ΔT2 (22.2 ± 4.4 and 15.1 ± 7.0) and ΔT2* values (24.3 ± 3.3 and 16.8 ± 8.1) (P = 0.005 and P < 0.001) between the control and the liver cirrhosis groups. There was a significant difference in the ΔT2* between the Child‐Pugh A and Child‐Pugh B/C groups (P < 0.001) and in the ΔT2 and ΔT2* between the control and Child‐Pugh B/C groups (P = 0.018 and P < 0.001).Conclusion: ΔT2 and ΔT2* are significantly larger in patients without liver cirrhosis than those with liver cirrhosis. ΔT2* is also significantly larger in Child‐Pugh class A patients than those in Child‐Pugh B/C. J. Magn. Reson. Imaging 2010;31:1379–1386.Keywords
This publication has 36 references indexed in Scilit:
- Chronic hepatitis: Role of diffusion‐weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammationJournal of Magnetic Resonance Imaging, 2008
- MR Elastography of Liver Tumors: Preliminary ResultsAmerican Journal of Roentgenology, 2008
- New Diagnostic Method for Liver Fibrosis and CirrhosisIntervirology, 2008
- MR Elastography to Assess Liver FibrosisRadiology, 2008
- MR Contrast Agents for Liver Imaging: What, When, HowRadioGraphics, 2006
- Noninvasive Markers of Fibrosis for Longitudinal Assessment of Fibrosis in Chronic Liver Disease: Are They Ready for Prime Time?American Journal of Gastroenterology, 2005
- Sampling Variability of Liver Fibrosis in Chronic Hepatitis CHepatology, 2003
- Liver positive enhancement after injection of superparamagnetic nanoparticles: Respective role of circulating and uptaken particlesMagnetic Resonance Imaging, 1997
- SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVERThe Lancet, 1986
- Complications following percutaneous liver biopsyJournal of Hepatology, 1986